Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting.

@article{Anwaruddin2005IschemiamodifiedAI,
  title={Ischemia-modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting.},
  author={Saif Anwaruddin and James Louis Januzzi and Aaron L. Baggish and Elizabeth Lee Lewandrowski and Kent B. Lewandrowski},
  journal={American journal of clinical pathology},
  year={2005},
  volume={123 1},
  pages={140-5}
}
We studied the role of ischemia-modified albumin (IMA) with standard biomarkers (myoglobin, creatine kinase-MB [CK-MB], troponin I [TnI]) in assessment of 200 patients with suspected myocardial ischemia admitted to the emergency department. Every case was reviewed by a cardiologist. A clinical diagnosis of ischemia was assigned and correlated with biomarker test results. Of the patients, 25 (13.0%) had myocardial ischemia. Receiver operating characteristic curves demonstrated IMA as highly… CONTINUE READING